Central Nervous System Neoplasm Clinical Trials

18 clinical trials for Central Nervous System Neoplasm across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Project: Every Child for Younger Patients With Cancer — RECRUITING
• Cerebrospinal Fluid Biomarkers for Brain Tumors — RECRUITING
• Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology — RECRUITING
• Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System — RECRUITING · PHASE2
• Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors — ACTIVE_NOT_RECRUITING
• Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital — NOT_YET_RECRUITING · NA
• Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia — ACTIVE_NOT_RECRUITING · PHASE2
• Collecting and Storing Tissue From Young Patients With Cancer — COMPLETED
• An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors — COMPLETED · NA
• Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery — COMPLETED
• Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types — COMPLETED · PHASE2
• Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA Study — WITHDRAWN
• Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas — COMPLETED · PHASE2
• Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors — COMPLETED · PHASE2
• High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors — COMPLETED · PHASE1
• Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors — COMPLETED
• Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors — COMPLETED · PHASE1

Refine this search